A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The āstrikingā findings showed an ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...
Verywell Health on MSN
Understanding metastatic castration-resistant prostate cancer
Medically reviewed by Matthew Wosnitzer, MD Key Takeaways Metastatic castration-resistant prostate cancer is an advanced form ...
A study from HKUMed demonstrates that prostate-specific antigen (PSA) screening can significantly reduce the incidence of ...
A new population-level study from Uppsala University has found that most men treated for non-metastatic prostate cancer according to current clinical guidelines have a favorable long-term prognosis.
"Advanced prostate cancer can have a devastating impact on patients and their quality of life," says Dr. Andrew Loblaw, Clinician Scientist and Head of Genitourinary Radiation Oncology Clinical ...
A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer. McGill University researchers at the Rosalind and Morris Goodman Cancer Institute (GCI ...
A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback